Yudisthra Ganeshadeva

Thanks . Had discussed 3 weeks IP with patient earlier and was wondering if that would be adequate

But fluid has cleared up significantly and cell counts down. My next question is how long I need to continue antibiotics for

Gram negative organism unfortunately - garden variety E Coli - non ESBL sensitive to Ceftazidime and most other antibiotics

Patient is slowly improving. Effluent looks clearer after a day of IP Ceftazidime + IP Cefazolin both his night cycle and during the Icodextrin day dwell. Waiting for the counts to confirm improvement

I am hoping I don't have to remove it as my only dialysis access would be a femoral vein (transhepatic is out of the picture due to the peritonitis)

The gastro says this is a common finding on CT scan post polypectomy and that is why clips are used and that since there is no inflammatory reaction it's unlikely to be a full blown perf

🎥 Explore the onconephrology case presentation series on the ISN Academy, in collaboration with ASON.

Tackle real-world challenges in cancer & kidney care.

📌 Latest case: AKI post haematopoietic stem cell transplantation (HSCT)
👉https://academy.theisn.org/onconephrologycases

Removal would be simple because I inserted the catheter

On fluconazole antifungal - considered an echinocandin at the outset considering the microperf

#AskRenal

Should I remove the tenckhoff and reinsert later or try intraperitoneal antibiotics first?

CT scan shows multiple surgical clips in ascending colon, hepatic flexure and splenic flexure and distal transverse colon. There is extraluminal air surrounding hepatic flexure

Murky light brown PD fluid in bag

Patient on Automated PD presents with hypotension, abdominal pain , fever for 2 days. Symptoms developed after colonoscopy with polypectomy.

Pseudoaneurysm of dialysis fistula with impending rupture
#POCUS

Awesome #nephmadness write up about resistant #hypertension renal denervation vs. novel drugs @stephanietr612.bsky.social @jordybc.bsky.social and visual abstracts @nephroseeker.medsky.social …And troubling AI-generated kidney art with tablet-shaped electroshockers i@littlebiggloms.bsky.social

Dear ASDIN Members: Due to the importance of this message below to our field, ASDIN is sharing the Medtronic media statement with our membership. ASDIN will continue to advocate on behalf of our members and will work with other providers to continue availability of endoAVF options for patients. Medtronic Statement Medtronic has made the decision to discontinue offering the Ellipsys ™ Vascular Access System for arteriovenous fistula (AVF) creation in all geographies. In a commitment to our customers, we will ensure they have up to 12 months of supply and up to six months of field, clinical, and cannulation support and will work closely with stakeholders to transition to alternative fistula creation solutions over the coming months. This decision will not limit patient or physician options for fistula creation. As the current standard of care, surgical fistula creation remains an option for any patient who would be a candidate for the Ellipsys system and an alternative endovascular fistula creation technology is commercially available in the U.S. and other regions. Medtronic remains committed to the arteriovenous market, focusing on effective fistula maintenance with our IN.PACTT™ AV drug-coated balloon and the Fortrex ™ HP PTA balloon catheter. While this was a difficult decision, this strategic shift will enable us to prioritize our resources towards fostering innovation and developing new therapies where we can have the most significant impact. This decision is aligned to Medtronic's active portfolio management work, an important lever to delivering on the company's long-term strategic and financial objectives.

Medtronic pulling out of the endovascular fistula creation market. Wow.

This is from the American Society of Diagnostic and Interventional Nephrology. And can't find this information on the medtronic website or with google. That may be a me problem though.

#NephMadness 2020: HD Access Region Submit your picks! | NephMadness 2020 | #NephMadness | #HDaccessRegion Selection Committee Member: Monnie Wasse @wasse_m Haimanot (Monnie) Wasse is Professor and Vice Chairperson in the Department …

Throwback to the #NephMadness percutaneous AVF discussion

ajkdblog.org/2020/03/13/n...

TCC at right PUJ causing right obstructive uropathy. Growing into proximal ureter #POCUS

TCC at the PUJ of the Right Kidney causing obstructive uropathy

FDA greenlights first clinical trials for genetically modified pig kidney transplants in humans Two companies have received FDA approval to conduct clinical trials transplanting genetically modified pig kidneys into patients with kidney failure

Omg omg omg

www.kidneyfund.org/article/fda-...

Can subcut Rituximab be used in Lupus Nephritis? Would save a lot of time

Amazing that people think anyone misses X as a site for professional development. To me personally X will remain just a place to catch up on news and occasionally criticize politicians in my country

A Kaplan-Meier survival curve showing cumulative survival over a 28-day in-hospital stay period for four groups: "Vaccinated without AKI" (blue line), "Vaccinated with AKI" (red line), "Not Vaccinated without AKI" (green line), and "Not Vaccinated with AKI" (orange line). The x-axis represents in-hospital stay in days, and the y-axis represents cumulative survival. The survival rate decreases more sharply in the "Not Vaccinated with AKI" group, followed by the "Vaccinated with AKI" group. The "Vaccinated without AKI" group has the highest survival, followed by the "Not Vaccinated without AKI" group. A log-rank test shows a p-value of 0.026, indicating a statistically significant difference in survival between the groups.

Research shows that COVID-19 vaccination reduces the risk of AKI and 28-day mortality in hospitalized patients with severe COVID-19. 📉💉

Learn more about the protective effects of vaccination! @Froylan_EndoMD @cjkhd.bsky.social @csnscn.bsky.social #COVID19 #Vaccination #KidneyHealth #CJKHD

Tuberculosis rates plunge when families living in poverty get a monthly cash payout A program in Brazil that gives a monthly cash sum to families living in poverty has an unexpected — and welcome result. A new study shows that it is dramatically reducing tuberculosis rates.

There’s a good reason why we call tuberculosis a social disease

TB rates plunge when families living in poverty get a monthly cash payout

www.npr.org/sections/goa...

HPV vaccine stops 90% of cervical cancer cases England began vaccinating teenage girls in 2008 and results show it is paying off.

I will never get tired of posting articles like this.

www.bbc.com/news/article...

@anastasiasmihaili.bsky.social hi. @tulunsokit here

Please pass this along, thank you.

Happy New Year 2025 guys
And Happy Hannukah as well

Fatal dengue virus infection in an unvaccinated traveler - European Journal of Clinical Microbiology & Infectious Diseases Dengue is an increasing threat to individuals living in or visiting endemic countries. Effective vaccines have become available, but their use in travelers is typically only recommended to individuals...

Fatal dengue virus infection in an unvaccinated traveler (from Guadeloupe)

"We present a fatal case of severe dengue in an unvaccinated traveler without known prior dengue virus infection but longitudinal serologic and molecular evidence for secondary infection"

link.springer.com/article/10.1...

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide This cohort study investigates whether semaglutide prescription is associated with increased risk of nonarteritic anterior ischemic optic neuropathy among patients with type 2 diabetes and patients wh...

Just saw this article
NAION incidence increased with Semaglutide use. RR around 4.8

jamanetwork.com/journals/jam...